Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next
Sana Biotechnology’s stock skyrocketed mid-week after a bold endorsement from a well-known tech investor. On Oct. 15, SANA shares jumped over 25% in a single session, closing at $5.62 ts2.tech. In intraday trading the stock even hit roughly $6.55 before paring back gains ts2.tech. The catalyst? A viral post on social media. Hedge fund manager Eric Jackson — known for spotting high-growth plays — proclaimed on X that “Biotech is back… $SANA looks like the next 100-bagger platform”. He pointed to an improving macro backdrop spurring a rotation “from megacaps to growth” stocks benzinga.com benzinga.com. Jackson’s ultra-bullish tweet injected a burst of momentum into Sana, with Benzinga reporting that the stock soared early Wednesday after his call went public ts2.tech. In fact, trading activity was so frenzied that exchanges halted SANA multiple times for volatility cooling-off periods. This isn’t the first time a social-media shoutout has sent a small biotech flying, but the magnitude turned heads marketbeat.com. It underscores how investor sentiment can dramatically swing early-stage biotech stocks. Short-term traders piled in on the 100-bagger hype, while forums and chat rooms lit up with debate on whether Sana could truly multiply 100-fold. Company insiders, however, emphasize that fundamentals will determine